We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$287B
AUM Growth
+$18.5B
Cap. Flow
-$4.92B
Cap. Flow %
-1.71%
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$672M
2
AMAT icon
Applied Materials
AMAT
+$241M
3
KVUE icon
Kenvue
KVUE
+$220M
4
CRM icon
Salesforce
CRM
+$210M
5
PYPL icon
PayPal
PYPL
+$195M

Sector Composition

Rank Sector Weight
1 Technology 27.88%
2 Healthcare 12.64%
3 Financials 11.25%
4 Consumer Discretionary 11%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DJCO icon
2676
Daily Journal
DJCO
$778M
$872K ﹤0.01%
3,015
CRD.A icon
2677
Crawford & Co Class A
CRD.A
$669M
$869K ﹤0.01%
78,393
+41,940
+115% +$404K
MBWM icon
2678
Mercantile Bank Corp
MBWM
$1.05B
$864K ﹤0.01%
31,290
TRDA icon
2679
Entrada Therapeutics
TRDA
$267M
$860K ﹤0.01%
56,814
+43,827
+337% +$604K
PTVE
2680
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$857K ﹤0.01%
113,196
-47,797
-30% -$365K
PBPB
2681
DELISTED
Potbelly
PBPB
$854K ﹤0.01%
+97,254
New +$854K
MVBF icon
2682
MVB Financial
MVBF
$389M
$852K ﹤0.01%
40,422
+18,349
+83% +$345K
HLLY icon
2683
Holley
HLLY
$384M
$850K ﹤0.01%
+207,913
New +$620K
XFOR icon
2684
X4 Pharmaceuticals
XFOR
$460M
$850K ﹤0.01%
+14,604
New +$750K
DAKT icon
2685
Daktronics
DAKT
$1.04B
$847K ﹤0.01%
+132,307
New +$776K
CDZI icon
2686
Cadiz
CDZI
$291M
$844K ﹤0.01%
+207,836
New +$918K
ASTS icon
2687
AST SpaceMobile
ASTS
$21.5B
$841K ﹤0.01%
+178,949
New +$928K
HCI icon
2688
HCI Group
HCI
$2.41B
$839K ﹤0.01%
13,576
ESQ icon
2689
Esquire Financial Holdings
ESQ
$1.14B
$837K ﹤0.01%
18,294
RLX icon
2690
RLX Technology
RLX
$2.46B
$836K ﹤0.01%
472,400
+21,000
+5% +$47K
PKE icon
2691
Park Aerospace
PKE
$819M
$836K ﹤0.01%
60,587
CGEM icon
2692
Cullinan Oncology
CGEM
$1.14B
$832K ﹤0.01%
77,311
+5,103
+7% +$54.2K
MG icon
2693
Mistras Group
MG
$512M
$830K ﹤0.01%
+107,537
New +$800K
KPTI icon
2694
Karyopharm Therapeutics
KPTI
$48M
$830K ﹤0.01%
30,902
-87,667
-74% -$3.78M
BLBD icon
2695
Blue Bird Corp
BLBD
$2.18B
$826K ﹤0.01%
36,752
DC icon
2696
Dakota Gold
DC
$804M
$824K ﹤0.01%
282,228
+209,994
+291% +$692K
UTMD icon
2697
Utah Medical Products
UTMD
$225M
$824K ﹤0.01%
8,839
INDA icon
2698
iShares MSCI India ETF
INDA
$6.63B
$823K ﹤0.01%
+18,839
New +$780K
GNE icon
2699
Genie Energy
GNE
$383M
$823K ﹤0.01%
+58,213
New +$862K
PETS icon
2700
PetMed Express
PETS
$42.3M
$823K ﹤0.01%
59,674

Similar funds

Nuveen's Q2 2023 Portfolio in Review

As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
  • Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
  • Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
  • Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
  • Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
  • Nuveen opened 280 new positions and closed 179 in Q2 2023.
  • Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.